142 related articles for article (PubMed ID: 27091219)
1. A prospective study of Trichomonas vaginalis and prostate cancer risk among African American men.
Fowke JH; Han X; Alderete JF; Moses KA; Signorello LB; Blot WJ
BMC Res Notes; 2016 Apr; 9():224. PubMed ID: 27091219
[TBL] [Abstract][Full Text] [Related]
2. Trichomonas vaginalis infection and risk of prostate cancer: associations by disease aggressiveness and race/ethnicity in the PLCO Trial.
Marous M; Huang WY; Rabkin CS; Hayes RB; Alderete JF; Rosner B; Grubb RL; Winter AC; Sutcliffe S
Cancer Causes Control; 2017 Aug; 28(8):889-898. PubMed ID: 28669054
[TBL] [Abstract][Full Text] [Related]
3. Persistence of Trichomonas vaginalis serostatus in men over time.
Sutcliffe S; Alderete JF; Neace C; Joyce PA; Gaydos CA; Huth JI; Mucci LA; Signorello LB
Cancer Causes Control; 2015 Oct; 26(10):1461-6. PubMed ID: 26223890
[TBL] [Abstract][Full Text] [Related]
4. Trichomonas vaginalis serostatus and prostate cancer risk in Egypt: a case-control study.
Saleh NE; Alhusseiny SM; El-Zayady WM; Aboelnaga EM; El-Beshbishi WN; Saleh YM; Abou-ElWafa HS; El-Beshbishi SN
Parasitol Res; 2021 Apr; 120(4):1379-1388. PubMed ID: 33159459
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study.
Stark JR; Judson G; Alderete JF; Mundodi V; Kucknoor AS; Giovannucci EL; Platz EA; Sutcliffe S; Fall K; Kurth T; Ma J; Stampfer MJ; Mucci LA
J Natl Cancer Inst; 2009 Oct; 101(20):1406-11. PubMed ID: 19741211
[TBL] [Abstract][Full Text] [Related]
6. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer.
Sutcliffe S; Giovannucci E; Alderete JF; Chang TH; Gaydos CA; Zenilman JM; De Marzo AM; Willett WC; Platz EA
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):939-45. PubMed ID: 16702374
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for Trichomonas vaginalis infection among adults in the U.S., 2013-2014.
Tompkins EL; Beltran TA; Gelner EJ; Farmer AR
PLoS One; 2020; 15(6):e0234704. PubMed ID: 32544192
[TBL] [Abstract][Full Text] [Related]
8. Trichomonas vaginalis infection and risk of advanced prostate cancer.
Shui IM; Kolb S; Hanson C; Sutcliffe S; Rider JR; Stanford JL
Prostate; 2016 May; 76(7):620-3. PubMed ID: 26818005
[TBL] [Abstract][Full Text] [Related]
9. Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial.
Sutcliffe S; Alderete JF; Till C; Goodman PJ; Hsing AW; Zenilman JM; De Marzo AM; Platz EA
Int J Cancer; 2009 May; 124(9):2082-7. PubMed ID: 19117055
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer.
Chen YC; Huang YL; Platz EA; Alderete JF; Zheng L; Rider JR; Kraft P; Giovannucci E; Sutcliffe S
Cancer Causes Control; 2013 Jan; 24(1):175-80. PubMed ID: 23179660
[TBL] [Abstract][Full Text] [Related]
11. Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women.
Schwebke JR; Gaydos CA; Davis T; Marrazzo J; Furgerson D; Taylor SN; Smith B; Bachmann LH; Ackerman R; Spurrell T; Ferris D; Burnham CA; Reno H; Lebed J; Eisenberg D; Kerndt P; Philip S; Jordan J; Quigley N
J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29167292
[TBL] [Abstract][Full Text] [Related]
12. Demographic and behavioural risk factors associated with
Abdallah I; Armstrong-Mensah E; Alema-Mensah E; Jones C
BMJ Open; 2017 Aug; 7(7):e013486. PubMed ID: 28765124
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Seropositivity to Trichomonas vaginalis between Men with Prostatic Tumor and Normal Men.
Kim JH; Moon HS; Kim KS; Hwang HS; Ryu JS; Park SY
Korean J Parasitol; 2019 Feb; 57(1):21-25. PubMed ID: 30840795
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Prevalence of Trichomonas vaginalis Infection Among Persons Aged 15 to 59 Years: United States, 2018.
Lewis FMT; Spicknall IH; Flagg EW; Papp JR; Kreisel KM
Sex Transm Dis; 2021 Apr; 48(4):232-237. PubMed ID: 33492095
[TBL] [Abstract][Full Text] [Related]
15. Trichomonas vaginalis infection and prostate-specific antigen concentration: Insights into prostate involvement and prostate disease risk.
Langston ME; Bhalla A; Alderete JF; Nevin RL; Pakpahan R; Hansen J; Elliott D; De Marzo AM; Gaydos CA; Isaacs WB; Nelson WG; Sokoll LJ; Zenilman JM; Platz EA; Sutcliffe S
Prostate; 2019 Oct; 79(14):1622-1628. PubMed ID: 31376187
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte Lysis and Cytokine Induction by the Human Sexually Transmitted Parasite Trichomonas vaginalis.
Mercer F; Diala FG; Chen YP; Molgora BM; Ng SH; Johnson PJ
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004913. PubMed ID: 27529696
[TBL] [Abstract][Full Text] [Related]
17. Trichomonas vaginalis, HIV, and African-Americans.
Sorvillo F; Smith L; Kerndt P; Ash L
Emerg Infect Dis; 2001; 7(6):927-32. PubMed ID: 11747718
[TBL] [Abstract][Full Text] [Related]
18. Aptima
Bruni MP; Freitas da Silveira M; Stauffert D; Bicca GLO; Caetano Dos Santos C; da Rosa Farias NA; Golparian D; Unemo M
Sex Transm Infect; 2019 Mar; 95(2):129-132. PubMed ID: 30154157
[TBL] [Abstract][Full Text] [Related]
19. Global epidemiology of Trichomonas vaginalis.
Poole DN; McClelland RS
Sex Transm Infect; 2013 Sep; 89(6):418-22. PubMed ID: 23744960
[TBL] [Abstract][Full Text] [Related]
20. Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care.
Quinlivan EB; Patel SN; Grodensky CA; Golin CE; Tien HC; Hobbs MM
Sex Transm Dis; 2012 Sep; 39(9):671-7. PubMed ID: 22902662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
